FABP1 and cardiovascular disorder: Other limitations of our systematic review include: a limited number of articles in each analysis and inability to analyze other important adverse outcomes, such as cardiovascular disease and rapid renal decline, or other tubular injury markers, such as L-FABP, owing to the restricted number of qualified articles available.